Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Net Cash Flow (2016 - 2025)

AtriCure (ATRC) has disclosed Net Cash Flow for 16 consecutive years, with $19.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Net Cash Flow rose 374.24% to $19.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $44.0 million, a 13.2% increase, with the full-year FY2025 number at $44.0 million, up 13.2% from a year prior.
  • Net Cash Flow was $19.5 million for Q4 2025 at AtriCure, down from $30.1 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $43.6 million in Q1 2021 to a low of -$27.6 million in Q3 2021.
  • A 5-year average of $6.3 million and a median of $6.5 million in 2021 define the central range for Net Cash Flow.
  • Peak YoY movement for Net Cash Flow: surged 761.06% in 2021, then crashed 297.59% in 2024.
  • AtriCure's Net Cash Flow stood at $3.9 million in 2021, then skyrocketed by 132.43% to $9.0 million in 2022, then crashed by 60.1% to $3.6 million in 2023, then plummeted by 297.59% to -$7.1 million in 2024, then skyrocketed by 374.24% to $19.5 million in 2025.
  • Per Business Quant, the three most recent readings for ATRC's Net Cash Flow are $19.5 million (Q4 2025), $30.1 million (Q3 2025), and $17.4 million (Q2 2025).